Blog about Hemp and CBD


Cannabinoids for fibromyalgia

Background: This review is one of a series on drugs used to treat fibromyalgia. Fibromyalgia is a clinically well-defined chronic condition of unknown aetiology characterised by chronic widespread pain that often co-exists with sleep problems and fatigue affecting approximately 2% of the general population. People often report high disability levels and poor health-related quality of life (HRQoL). Drug therapy focuses on reducing key symptoms and disability, and [...]

European Parliament signs off on raising EU THC limit to 0.3%

The European Parliament has voted in favor of increasing the authorized THC level for industrial hemp “on the field” from 0.2% to 0.3%, a critical step in the process of re-establishing that level of THC for European hemp. The proposal, long advocated by the European Industrial Hemp Association (EIHA), was included in the Common Agricultural Policy (CAP) reform adopted by the Parliament today. “This is an historic moment [...]

European Commission reverses position: CBD not a narcotic

The European Commission has reversed its preliminary assessment on CBD, and said the compound is not a narcotic. The reversal comes in the wake of a judgment in which the European Union Court of Justice (ECJ) ruled that CBD cannot be regarded as narcotic, and that CBD products should enjoy the same free movement of goods between and among member states as other legal products. CBD “can [...]

Cannabis Sativa L Biomass and legal THC content below 0,2%

Cannabis Sativa L. biomass is produced and sold in accordance to Reg. (UE) No. 1307/2013 and Reg. (EU) No. 1115/2017 supplementing Regulation (EU) No 1307/2013 and Reg. N. 1308/2013 and Italian Law No. 242/2016. The cultivation of industrial hemp has a special aid scheme. Is allowed the cultivation of hemp varieties listed in the common catalog of varieties of agricultural plant species. The varieties allowed [...]

The bioengineering of cannabis

Genetic modification could enable industrial-scale production of cannabinoids that have pharmaceutical potential. Cannabis is the only plant known to produce tetrahydrocannabinol (THC), but it remains an imperfect vessel for producing the chemical on an industrial scale. The psychoactive substance is normally found only in small outgrowths from the plant known as trichomes, which means that its stalk, stems and leaves are wasted biomass. Genetic engineering [...]

How Does Artificial Intelligence Fit into Cannabis Cultivation?

Close up of hemp buds Grit Daily report In a clandestine, 40,000-square-foot cultivation facility in northern Arizona, we met with the founders of CEAD, Royce Birnbaum and Adam Klaasmeyer, a company that develops artificial intelligence applications for the cannabis industry. These two are no strangers to innovation. Birnbaum, the lead back-end developer for the project, has had a career in developing systems for monitoring [...]

Cannabidiol in Anxiety and Sleep: A Large Case Series.

Cannabidiol (CBD) is one of many cannabinoid compounds found in cannabis. It does not appear to alter consciousness or trigger a “high.” A recent surge in scientific publications has found preclinical and clinical evidence documenting value for CBD in some neuropsychiatric disorders, including epilepsy, anxiety, and schizophrenia. Evidence points toward a calming effect for CBD in the central nervous system. Interest in CBD as a [...]


Cannabigerol Cannabigerol (CBG) is one of more than 120 identified cannabinoid compounds found in the plant genus Cannabis. Cannabigerol is the non-acidic form of cannabigerolic acid, the parent molecule from which other cannabinoids are synthesized. Cannabigerol is a minor constituent of cannabis. During growth, most of the cannabigerol is converted into other cannabinoids, primarily tetrahydrocannabinol (THC) or cannabidiol (CBD), leaving about 1% cannabigerol in the [...]


Cannabidiol Cannabidiol (CBD) is a phytocannabinoid discovered in 1940. It is one of 113 identified cannabinoids in cannabis plants and accounts for up to 40% of the plant's extract.[7] In 2018, clinical research on cannabidiol included preliminary studies of anxiety, cognition, movement disorders, and pain.[8] Cannabidiol can be taken into the body in multiple ways, including by inhalation of cannabis smoke or vapor, as an [...]

Go to Top